Congrats patty spears on such a well deserved award! 2023 Komen Research Advocacy Champion Award! UNC Lineberger #SABCS23 Susan G. Komen 👏👏

Perou lab and friend’s annual reunion! #SABCS23 Aleix Prat #PrecisionOncology Patricia Villagrasa HoadleyLab Benjamin C. Calhoun M.D., Ph.D. Qing Zhang patty spears UNC Lineberger @ChuckHarrellPhD sugarciare afernan4 Lisa Carey, MD, ScM, FASCO Katie Hoadley Yash Agrawal

UNC Lineberger has opened searches for basic+translational cancer research faculty positions. Creative scientists in molecular, cellular and computational areas applicable to cancer etiology, progression, metastasis + therapy are encouraged to apply. unc.peopleadmin.com/postings/265992

I took a deep dive on the new image feature on ChatGPT 4.0 for histology images and it is 🤯

Follow along below. Note, images are from publically available de-identified slides available on the internet.

While some cancers can be seen or felt, others may microscopic. 🔬

A new #AI tool, developed by researchers at UNC Surgery, Biomedical Engineering | UNC & NC State, and UNC Lineberger, will allow #surgeons to more accurately analyze and remove tumors during #BreastCancer surgery.

news.unchealthcare.org/2023/09/resear…

Very happy to be a co-author on this paper. It was great working with Philip Spanheimer on tissue procurement for single cell sequencing. UNC Dept of Pathology and Laboratory Medicine UNC Lineberger UNC BreastSPORE

How will the field of oncology change in 50 years? Lisa Carey, MD, Deputy Director of Clinical Sciences at UNC Lineberger Comprehensive Cancer Center, shared her thoughts with Becker's Hospital Review.

Read her prediction here: ow.ly/Kb5y50PLLTS

A new Trop2 ADC is about to become available for patients with HR+/HER2- MBC. In #TB01 , datopotamab deruxtecan (Dato-DXd) improved PFS over chemotherapy, with a trend towards improved overall survival. All grade ILD rates seen in the trial were low. #bcsm astrazeneca.com/media-centre/p…

Our residents and fellows visited Foundation Medicine yesterday as part of our Molecular Pathology course!

Intriguing results from the non-inferiority SOUND trial, led by the IEO team. Among 1463 pts with small breast tumors (median 1.1 cm, ~90% ER+) & negative axillary US, the omission of SLNB did not impact 5-year DDFS (97.7% with vs 98.0% w/o SLNB, p=0.02). jamanetwork.com/journals/jamao…

We are proud to host Dr. Kellie Machlus Kellie Machlus for the inaugural Walter Benson Path Back Home Lecture, which features UNC Dept of Pathology and Laboratory Medicine star alums! 🤩🤩 Welcome back! 🐏

Lead UNC BreastSPORE patient advocate patty spears giving a really important talk today at NCI on the patient perspectives and what they want and need to know about ctDNA - accessible, but we need to know if is actionable and saves lives! #bcsm

here is link (2/4 🧵) biorxiv.org/content/10.110…
#bcsm #lobmob #GlobMob

One highlight for breast pathologists to consider: “Regardless of extent of response to neoadjuvant chemotherapy plus pembrolizumab, panelists favored ongoing adjuvant pembrolizumab.” 2023 St. Gallen Consensus #breastpath #pathtwitter #pathx annalsofoncology.org/article/S0923-…

📢1/10 Out on nature our work ‘Spatial predictors of immunotherapy response in triple-negative breast cancer’ rdcu.be/dluy0 lead by Ali Lab and myself
👉To work, immunotherapy requires certain immune cell types, in proper functional state and spatial context
🧵👇

“This is sort of a groundbreaking, land-on-the-moon kind of moment for cancer care.” cnbc.com/2023/09/07/mic…

Shelton “Shelley” Earp, MD, has announced his intention to step down as Director of the UNC Lineberger Comprehensive Cancer Center, effective in June of 2024. A national search will commence this fall in the hope of naming a successor in Spring of 2024. unclineberger.org/news/earp-to-s…

Last week's Metastatic Breast Cancer meeting #MBCRC23 was terrific, bringing advocates & researchers together. UNC's Breast Tumor Donation Program and primary/mets biology studies well-represented, but this will take a village! #bcsm UNC BreastSPORE unclineberger.org/octr/our-resea…

This is me chasing down papers in PubMed instead of reading the ones I have and finishing the talk or manuscript…

coopERA: Interesting data for giredestrant+palbo vs. anastrozole+palbo.
-Similar Ki67 suppression
-Similar AEs

OncoAlert #bcsm